Monday, August 3, 2020

Eli Lilly begins stage-3 trial of Covid-19 antiviral drug

Eli Lilly has begun its stage-three trial of its promising antiviral treatment against Covid-19.


The American pharmaceutical company announced Monday it is rolling out the large-scale trial for patients in nursing homes and long-term care facilities.


Here's US correspondent Liling Tan with the details. 


IN: "Eli Lilly…

OUT: SOC

DUR: 40 seconds


ALL: http://www.fsnradionews.com/feeds/0803-EliLillycovidtrial-lt-all.mp3